Skip to main content
Healthcare

This cholesterol drug promised to be a game-changer. Why did it flop in the clinic — and is there still hope?

This cholesterol drug promised to be a game-changer. Why did it flop in the clinic — and is there still hope?

Feed excerpt — reported by Nature

Nature, Published online: 03 November 2026; doi:10.1038/d41586-026-03504-2Physicians were excited about several therapies that slash levels of lipoprotein(a) — an important cardiovascular risk factor. One major trial failed to show a benefit, and now scientists are scrambling to work out what that means.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Nature →

Original Source

This article was syndicated from Nature. All rights remain with the original publisher.